SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Infectious Diseases Referral — Arthur Ashe

PatientArthur Ashe
Date of birth1980-07-10
IdentifiersMRN HR-ML013-SYN; SSN (made up) 000-13-6620
Document date2026-01-12
AuthorVivian Tolliver, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Referral

HIV infection diagnosed four months ago with cerebral toxoplasmosis and a CD4 count of 58, in a 45-year-old man who also has coronary artery disease after two bypass operations. Please review his antiretroviral regimen and its interactions with his cardiac medicines, and advise on opportunistic-infection prophylaxis, the monitoring schedule, and vaccines, so that we can co-manage his care. [S]

Urgency: Routine, within four weeks, on the same day as his four-week primary care visit. [S]

Questions for the consultant:

History of Present Illness

Admitted four months ago with right-hand weakness; MRI showed a single ring-enhancing left frontoparietal lesion, and stereotactic biopsy showed Toxoplasma. HIV was diagnosed during that admission, with a viral load of 186,000 copies/mL and a CD4 count of 58. The genotype showed no resistance mutations; hepatitis B surface antigen, surface antibody, and core antibody were negative; hepatitis C antibody negative; hepatitis A antibody positive; interferon-gamma release assay negative; Toxoplasma IgG positive. He completed six weeks of pyrimethamine, sulfadiazine, and leucovorin, and has taken trimethoprim-sulfamethoxazole double strength twice daily since. Bictegravir, emtricitabine, and tenofovir alafenamide were started two weeks into toxoplasmosis treatment. His right hand has recovered. Today, after about 15 weeks of therapy: viral load 42 copies/mL, CD4 156, hemoglobin 13.0 g/dL, potassium 4.9 mmol/L, creatinine 1.18 mg/dL (0.98 before treatment), ALT 30, LDL 88 mg/dL. Coronary disease: myocardial infarction at 36, quadruple bypass the same year, and a double bypass for recurrent angina at 39, with a blood transfusion during that operation; no angina now. He takes aspirin 81 mg and atorvastatin 80 mg, ezetimibe was added today, and he has sublingual nitroglycerin. PCV20, a first hepatitis B vaccine dose, and a first meningococcal ACWY dose were given today. He has asked that his diagnosis and results be shared with no one without his consent [S]

Historical basis. These claims are historical evidence, not findings from a modern examination.

2 later historical claims are omitted because they describe events after the index age. See the teaching note.

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Bictegravir 50 mg, emtricitabine 200 mg, and tenofovir alafenamide 25 mg, one tablet by mouth once daily; take two hours before or six hours after antacids, calcium, iron, or magnesiumOne tablet by mouth once dailyOral route2025-09-25activeS
Pyrimethamine 25 mg oral tablet, 200 mg once, then three tablets (75 mg) by mouth daily for six weeks; course completed before intakeThree tablets by mouth daily after a 200 mg loading doseOral route2025-09-11 to 2025-10-23completedS
Sulfadiazine 500 mg oral tablet, three tablets (1500 mg) by mouth every 6 hours for six weeks; course completed before intakeThree tablets by mouth every 6 hoursOral route2025-09-11 to 2025-10-23completedS
Leucovorin 10 mg oral tablet, two tablets (20 mg) by mouth daily with pyrimethamine; course completed before intakeTwo tablets by mouth dailyOral route2025-09-11 to 2025-10-23completedS
Sulfamethoxazole 800 mg and trimethoprim 160 mg (double strength), one tablet by mouth twice dailyOne tablet by mouth twice dailyOral route2025-10-23 to 2026-10-19completedS
Aspirin 81 mg delayed-release oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2016-07-31activeS
Atorvastatin 80 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2016-08-01activeS
Ezetimibe 10 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2026-01-12activeS
Nitroglycerin 0.4 mg sublingual tablet, one tablet under the tongue every 5 minutes as needed for chest pain, up to 3 tablets; call 911 if pain is not better 5 minutes after the first tabletOne tablet under the tongue every 5 minutes as needed for chest pain, up to 3 dosesSublingual route2016-08-01activeS

Problems

ProblemClinical statusVerificationCodeProvenance
HIV infection, diagnosed about four months before intake with a CD4 count of 58 cells/uL and cerebral toxoplasmosis (an AIDS-defining illness); on antiretroviral therapy since; synthetic modern episode linked to the documented transfusion-acquired infectionactiveconfirmed B20S — Synthetic modern coding of the documented HIV infection and AIDS diagnosis; B20 stays the code after an AIDS-defining illness, however well the infection is controlled.
Cerebral toxoplasmosis, single left-sided lesion with right-hand weakness, diagnosed by stereotactic biopsy; six weeks of acute treatment completed; weakness recovered; on maintenance therapyactiveconfirmed B58.2S — Synthetic modern coding of the documented 1988 toxoplasmosis; the modern diagnosis was by biopsy rather than removal of the mass.
Coronary artery disease after two bypass operations (quadruple, then double), no angina; synthetic modern episode linked to the documented 1979 and 1983 operationsactiveconfirmed I25.10S — Synthetic modern diagnosis; the history remains D.
Old myocardial infarction at age 36activeconfirmed I25.2S — Synthetic coded history of the documented 1979 heart attack.
Hyperlipidemia, on high-intensity statinactiveconfirmed E78.5S — Synthetic diagnosis; no cholesterol value from his lifetime is used.

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
July 31, 1979Heart attack at age 36 while teaching tennis to young people, followed by quadruple coronary artery bypass surgeryD (CLM-0002)
1983Second (double) bypass operation for recurrent chest pain, with a blood transfusionD (CLM-0003)
1988Right-arm weakness from a left-sided brain mass, removed and found to be toxoplasmosis; HIV and AIDS diagnosed, believed to have been acquired from the transfusion during the 1983 operationD (CLM-0004, CLM-0005)

Family History

RelativeConditionAge at deathEvidence
motherDied at 27 of complications from surgery; atherosclerotic heart disease at an early age reportedD (CLM-0007)
fatherHeart attacks at 55 and 59; atherosclerotic heart disease at an early age reportedD (CLM-0007)

Social History

Vital Signs

DateMeasureValueUnitProvenance
2026-01-12Body height185cmS
2026-01-12Body weight72kgS
2026-01-12Body mass index (BMI) [Ratio]21kg/m2S
2026-01-12Systolic blood pressure118mm[Hg]S
2026-01-12Diastolic blood pressure74mm[Hg]S
2026-01-12Heart rate72/minS
2026-01-12Respiratory rate14/minS
2026-01-12Body temperature36.7CelS
2026-01-12Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-01-12HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection42{copies}/mLBelow 20 copies/mL (limit of quantification); 0 means HIV-1 RNA not detectedHighS
2026-01-12CD3+CD4+ (T4 helper) cells [#/volume] in Blood156/uL500-1500 /uLLowS
2026-01-12Leukocytes [#/volume] in Blood by Automated count4.210*3/uL4-11 10*3/uLNormalS
2026-01-12Hemoglobin [Mass/volume] in Blood13g/dL13.2-16.6 g/dLLowS
2026-01-12Platelets [#/volume] in Blood by Automated count19810*3/uL150-400 10*3/uLNormalS
2026-01-12Sodium [Moles/volume] in Serum or Plasma139mmol/L135-145 mmol/LNormalS
2026-01-12Potassium [Moles/volume] in Serum or Plasma4.9mmol/L3.5-5.1 mmol/LNormalS
2026-01-12Creatinine [Mass/volume] in Serum or Plasma1.18mg/dL0.74-1.35 mg/dLNormalS
2026-01-12Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M78mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-01-12Glucose [Mass/volume] in Serum or Plasma92mg/dL70-99 mg/dLNormalS
2026-01-12Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma30U/L7-56 U/LNormalS
2026-01-12Cholesterol [Mass/volume] in Serum or Plasma158mg/dL<=199 mg/dLNormalS
2026-01-12Cholesterol in HDL [Mass/volume] in Serum or Plasma40mg/dL>=40 mg/dLNormalS
2026-01-12Triglyceride [Mass/volume] in Serum or Plasma150mg/dL<=149 mg/dLHighS
2026-01-12Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation88mg/dL<=99 mg/dLNormalS
2026-01-12Hemoglobin A1c/Hemoglobin.total in Blood5.4%<=5.6%NormalS
2026-01-12Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]5{score}S
2026-01-12Total score [AUDIT-C]1{score}S

Assessment

Plan of Treatment